PHK
BEAM icon

Point72 Hong Kong’s Beam Therapeutics BEAM Stock Holding History

Point72 Hong Kong’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,325
Closed -$1.6M – 460
2024
Q1 		$1.6M Buy
+48,325
New +$1.51M 0.08% 223
2022
Q4 		– Sell
-12,477
Closed -$594K – 241
2022
Q3 		$594K Buy
+12,477
New +$712K 0.02% 686
2022
Q2 		– Sell
-5,763
Closed -$330K – 1924
2022
Q1 		$330K Buy
+5,763
New +$378K 0.01% 807
2021
Q4 		– Sell
-1,888
Closed -$164K – 1896
2021
Q3 		$164K Buy
+1,888
New +$190K 0.01% 1225

Other funds holding BEAM

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Point72 Hong Kong's BEAM Position: Q2 2024 in Review

Point72 Hong Kong sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 48,325 shares — an estimated $1.6M sold.

Point72 Hong Kong first reported a position in BEAM in Q3 2021 and held it in 4 quarters. The position peaked at $1.6M in Q1 2024. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • Point72 Hong Kong reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 48,325 Beam Therapeutics shares in Q2 2024, an estimated $1.6M.
  • Point72 Hong Kong first reported a position in Beam Therapeutics in Q3 2021 and held it in 4 quarters.
  • Point72 Hong Kong's Beam Therapeutics position peaked at $1.6M in Q1 2024.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.